Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. TAVI: Mixed results for Edwards’ Sapien valve in latest Partner analysis
Findings from the latest analysis of the Partner study of Edwards Lifesciences’ Sapien transcatheter aortic valve replacement suggest the procedure may beat traditional aortic valve replacement surgery only when conducted transfemorally.
2. Medtronic CEO Omar Ishrak: Emerging markets “the most important ones”
Emerging medical device markets will play a huge role in Medtronic’s strategy moving forward and the U.S.’s Affordable Care Act won’t, according to Medtronic CEO Omar Ishrak.
1. Open heart surgery beats stents in 5-year Freedom trial
Coronary artery bypass surgery is better than stenting in patients with diabetes or complex heart disease, according to a 5-year study comparing open heart surgery with percutaneous coronary intervention.
